Date post: | 25-Dec-2015 |
Category: |
Documents |
Upload: | ernest-parrish |
View: | 221 times |
Download: | 0 times |
Global and National Response to AMR
Chatham House/Murdoch University
AMR Symposium
Chris Baggoley8 December 2014
Drivers of AMR
Globalisation and
international travel
Poor infection prevention and
control
Collapse of antibiotic
research and development
Antibiotic resistance
Poor and unrestrained
use of antibiotics
Substandard
antibiotics
Ministerial Conference
Antibiotic Resistance
“Joining Forces for Future Health”
The Hague – 25 to 26 June 2014
Antimicrobial resistance:
global report on surveillance.
ISBN 978 92 4 156474 8
© World Health Organization 2014
Total Outpatient antibiotic use in 26 European countries in
2002
0
5
10
15
20
25
30
35
FR GR LU PT IT BE SK HR PL IS IE ES FI BG CZ SI SE HU NO UK DK DE LV AT EE NL
DD
D p
er 1
000
inh.
per
day
OthersJ01B+J01G+J01X
Sulfonamides andtrimethoprim J01E
Quinolones J01M
Macrolides, Lincosam.,Streptogramins J01F
Tetracyclines J01A
CephalosporinsJ01D
Penicillins J01C
Source: ESAC Website
AUS
What is already in place?
• Strong regulatory systems to ensure safe, effective, high quality medicines
• Most antibiotics available by prescription only
• National standards – Infection prevention and control, antimicrobial stewardship in hospitals
• Some surveillance of AMR, and antibiotic use in hospitals
• BUT, some critical gaps, and no comprehensive national strategy to guide action and ensure efforts are coordinated
Standard 7Blood and Blood
Products
Standard 10Preventing Falls and
Harm from Falls
The NSQHS Standards
Standard 1Governance for Safety and
Quality in Health Service Organisations
Standard 2Partnering withConsumers
Standard 4Medication Safety
Standard 3Healthcare AssociatedInfections
Standard 8Preventing and
Managing Pressure Injuries
Standard 9Recognising and
Responding to ClinicalDeterioration in Acute
Health Care
Standard 5Patient Identificationand ProcedureMatching
Standard 6ClinicalHandover
Antimicrobial prescribing practice
in Australia: results of the 2013
National Antimicrobial Prescribing
Survey
www.safetyandquality.gov.au
National leadership to drive action
• Importance of strong leadership, commitment to action, and funding to support development and implementation of a national plan
• Australian AMR Prevention and Containment Steering Group established February 2013
• $11.9 million allocated in 2013-14 Federal Budget
• Supported by an advisory group to provide expert clinical and technical advice on AMR
National AMR Strategy
• Proposed goal: To slow the development and spread of AMR and conserve the effectiveness of antimicrobials
• Objectives: To achieve this goal, we will focus our efforts on:
improving surveillance preventing infections and the spread of
resistant infections and improving the appropriate use of antimicrobials
Developing a National Antimicrobial
Resistance
Strategy for Australia – October 2014
ISBN: 978-1-74186-192-1
Online: ISBN: 978-1-74186-193-8
Publications approval number: 10917
Key elements1. Infection prevention and control
2. Surveillance
3. Antimicrobial stewardship
4. Communication and Education
5. International engagement
6. Research and Development
7. Governance
Communication & Education
NPSMedicineWise ‘Resistance Fighter’ public awareness campaign
• Training modules for medical students and junior hospital medical staff
• Some education activities available for GPs, but not compulsory
• Gaps – very difficult to achieve sustained changes in consumer attitudes and behaviours - continue with efforts to increase public awareness of AMR, drivers, and appropriate use of antibiotics
Source: Microbiol. Mol. Biol. Rev. 2010, 74(3):417. DOI: Julian Davies and Dorothy Davies Resistance Origins and Evolution of Antibiotic
Origin and Evolution of Antibiotic Resistance
ACSQHC: Elements of HAI Standard
Systems and governance
Infection prevention policies and
protocols
Managing patients with infections
Antimicrobial stewardship
Cleaning, disinfection and sterilisation
Consumer information
Infection Prevention & Control
National Safety and Quality Health Service (NSQHS) Standards
• Standard 3: Preventing and Controlling Healthcare Associated Infections
• Australian Guidelines for the Prevention and Control of Infection in Healthcare
• National Hand Hygiene Initiative
• Gaps – general practice, aged care, veterinary practice, animal health
SurveillanceResistance• AGAR is a collaboration of 30 public and private laboratories
around Australia which collects, analyses and reports on trends in the level of AMR in bacteria causing important and life threatening infections in humans.
Antibiotic Usage• NAUSP collects data on antibiotic utilisation in Australian
hospitals - 80% national representation of principal referral hospital beds.
• DUSC collects and analyses data on medicines dispensed by community pharmacies
Appropriateness• NAPS – annual point prevalence survey on the
appropriateness of antimicrobial prescribing in hospitals
Surveillance• Gaps - current initiatives not comprehensive/nationally
representative. Need data from general practice, aged care, as well as antibiotic use in animals and agriculture
• New initiative to improve data on AMR and AU in human health, including establishing passive and targeted surveillance systems for AMR and AU across hospital, community and aged care settings and a national alert system to inform clinicians and policy-makers about emerging AMR trends.
• Agriculture – report on antimicrobial usage monitoring and resistance surveillance activities in the animal and agriculture sector in Australia, and overseas to inform future action
Surveillance of antibiotic usage Community
– PBS, Pharmacies – usage data– Medicare – no. of prescriptions
Animal - APVMA – antibiotic volumes Hospital
– National Antibiotic Usage Surveillance Program (NAUSP) -covers 70% of acute referral beds – pharmacy dispensing data
Appropriateness – – National Antibiotic Prescribing Survey
Import and supply data – Therapeutic Goods Administration and the Australian
Pesticides and Veterinary Medicines Authority
Antimicrobial Stewardship• To date, efforts have focussed on
hospital settings• National Safety and Quality Health
Service Standard 3 requires AMS programs to be implemented
• Therapeutic Guidelines: Antibiotic
Gaps:• No equivalent approach in general
practice, aged care or animal health• Most antibiotics for humans are
prescribed in community settings, and evidence of increasing AMR in the community
• Antibiotic use in animal health???
Key components of AMR Stewardship
Hospitals
Leadership
AMR team
Local formulary
Education and training
Prescriber feedback
Measure performance
Clinical microbiology service
Community / primary care
Leadership
Therapeutic guidelines
Practice clinical audit
Education and training
Liaison with local laboratory
Patient education
Prescriber feedback
Antimicrobial Resistance Global Action Plan
“Going Forward” Strategic Technical Advisory Group
14 April 2014 - Keiji Fukuda (Geneva)